The School of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona, USA.
J Biomed Mater Res A. 2013 Sep;101(9):2515-25. doi: 10.1002/jbm.a.34554. Epub 2013 Jan 28.
We report the evaluation of dual-gelling poly(N-isopropylacrylamide)-based polymer systems as embolic agents for intracranial aneurysms. These hydrogels undergo gelation physically via temperature-responsiveness of poly(NIPAAm) and chemically through a Michael-addition reaction between thiol and vinyl functional groups on the copolymers. Cytotoxicity studies were performed for biocompatibility of the hydrogels. In vitro glass models were utilized to assess injectability and embolization using the gelling systems and an in vivo swine model was used as proof-of-concept for catheter delivery, injection, and occlusion properties of the hydrogels. Rheology creep tests were conducted for determination of viscoelastic behavior, and degradation of the hydrogels was also investigated. Live/dead and proliferation assays indicated good biocompatibility of the hydrogels. In vitro and in vivo assessment demonstrated that the hydrogels were easily delivered via catheters into the aneurysms. Slight recanalization was observed in vivo, with some adhesion of the gels to the balloon catheter seen in vitro. The materials show creep deformation occurring with time; however, the hydrogels did not degrade over the course of 1.5 year. With the possibility to engineer hydrogels bottom-up for particular applications, these studies show properties that need to be optimized for dual-gelling polymer systems to serve as liquid-to-solid embolic agents for aneurysm treatment.
我们报告了双重凝胶聚(N-异丙基丙烯酰胺)基聚合物系统作为颅内动脉瘤栓塞剂的评估。这些水凝胶通过聚(NIPAAm)的温度响应以及通过巯基和聚合物上的乙烯基官能团之间的迈克尔加成反应进行物理凝胶化和化学凝胶化。进行了细胞毒性研究以评估水凝胶的生物相容性。使用凝胶系统在体外玻璃模型中评估了可注射性和栓塞性,并且体内猪模型被用作水凝胶的导管输送、注射和闭塞特性的概念验证。进行了流变学蠕变测试以确定粘弹性行为,并且还研究了水凝胶的降解。活/死和增殖测定表明水凝胶具有良好的生物相容性。体外和体内评估表明,水凝胶可以通过导管轻松输送到动脉瘤中。体内观察到轻微的再通,体外观察到凝胶与球囊导管有些粘连。材料显示出随时间发生的蠕变变形;然而,水凝胶在 1.5 年内没有降解。通过有可能从底部设计水凝胶以用于特定应用,这些研究表明需要优化双重凝胶聚合物系统的性能,以作为用于治疗动脉瘤的液体到固体栓塞剂。